Overview This page contains the latest trade data of Antisera and other blood fractions. In 2020, Antisera and other blood fractions were the world's 9th most traded product, with a total trade of $172B. Between 2019 and 2020 the exports of Antisera and other blood fractions grew by 15.2%, from $149B to $172B. Trade in Antisera and other blood fractions represent 1.03% of total world trade.
Antisera and other blood fractions are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2020 the top exporters of Antisera and other blood fractions were Germany ($32.5B), Switzerland ($29.8B), United States ($24.8B), Ireland ($24B), and Belgium ($9.38B).
Imports In 2020 the top importers of Antisera and other blood fractions were United States ($34.7B), Germany ($22.9B), Switzerland ($11.5B), Netherlands ($10.4B), and Belgium ($8.52B).
Tariffs In 2018 the average tariff for Antisera and other blood fractions was 1.62%, making it the 6334th lowest tariff using the HS6 product classification.
Ranking Antisera and other blood fractions ranks 328th in the Product Complexity Index (PCI).